Market Discounts Recession; GDP, EPS Growth Worries Mount

– Our base case is U.S. virus peak in May and SPX bottoms around 2200-2400

– Now market doesn’t care that pandemic growth seems to be slowing in some places

– PMs seem to have written off 2020 and look to 2021, but EPS visibility low

Market Discounts Recession; GDP, EPS Growth Worries Mount
Source: FSInsight, Bloomberg

Having lived through three bad bear markets, I thought I’d seen everything. But the rapid demise of stock prices in this one is nothing short of astounding. These are historic times.

There are two things investors are afraid of, both of which remain hard to handicap, the extent of the coronavirus spread and the eventual knock on economic effects. The S&P 500 index is down over 29% since the Feb. 19 high of 3386.

What’s been baffling is that there are incipient signs the COVID-19 virus is coming under control in many of the hardest hit places.  As I’ve noted before, China, where the virus originated, is already showing lower infection and death rates, as is South Korea.  While you won’t see that in the screaming headlines, there are some who think the pandemic will slow. For example, Israeli Nobel Laureate Michael Levitt said recently that “the end of the pandemic is near.” 

Now increasing talk like that should stabilize the stock market—eventually. However, and this is a big however, there’s been significant damage to the investor psyche—no matter how obvious it becomes that the pandemic is over—and that could go on for a while. That is worrying short term.

Investors should look dispassionately at the market, but that is hard to do and at times like these when often sentiment wins out.  There’s an old Wall Street saying about bear markets, “When you should be buying, you won’t.”  I’m convinced that in the three to five-year time frame this is a buying opportunity, but the fear factor is too high for many to overcome. And that’s understandable.

I believe the coronavirus scare, though serious, has been overhyped and that in a few month’s time we will all be wondering why the market took it so badly. That doesn’t mean the broad market will recover and old high of 3386 on the SPX certainly looks a long way off now.

Unfortunately, the knock effects—again something I’ve written about previously—have already become a self-fulfilling prophecy in the oil market, where crude prices have plunged to $25 per barrel from over $60 a few months ago, on fears of a glut and lower energy consumption globally. While that might help consumers, it won’t help an already beaten up oil sector or their creditors, or employment levels. That will begin to affect the industries that sell to oil companies and car companies, and so on and so on, until the economy as a whole is hurt. Not to sound callous but stock prices probably reflect a declining profit growth much more than coronavirus itself, even though the latter started the whole thing rolling downhill.

The market just wants it all to stop and no one knows when that’s going to happen. There could be a negative wealth effect. People have lost gobs of money in their stock accounts and 401ks.  That hurts and could put a damper on consumer activity for a while, particularly if the market doesn’t stabilize. The bears are piling on as for the first time in many years—for most of them—their predictions have come true.

The market is desperately trying to estimate what this means for the global and U.S. economic growth, as well as profits. Here again there’s little data that can be said definitive, particularly as the outbreak hasn’t completely finished.

The estimates vary widely. Goldman Sachs, the investment bank, for example said Monday that its U.S. GDP growth forecast for the 1H20 was reduced to zero, with a decline of 5.0% for the second quarter. Ian Shepherdson, chief economist at Pantheon Macroeconomics, in a note to clients on Monday night said a 10% drop in possible in 2Q20 after a 2% drop in 1Q20. Ouch.

Others, however, don’t see it that bad. For example, The Wall Street Journal recently reported that its monthly economists’ survey expects, on average, gross domestic product to contract to 0.1% in 2Q vs a previous projection of 1.9%. They see growth of 1.2% this year, down from 1.9% Annual growth was 2.3% in 2019.

Just for comparison, Bespoke Investment Group says 5% declines are rare.  Since 1950, there have only been six prior quarters where GDP declined by 5% or more with the most recent being back in December 2008. Moreover, all those six quarters contractions of 5% or more were either immediately preceded or followed by another quarter of negative growth averaging a decline of over 2%.

My colleague Tom Lee has a base case that sees 65% probability of a U.S. peak case rate in May with a 2%-3% hit to 2Q GDP.  That suggests an SPX level of 2200-2400, roughly where we are now.

Market Discounts Recession; GDP, EPS Growth Worries Mount
Source: FSInsight, Bloomberg

It’s difficult to estimate what this means for EPS of the SPX in 2020. It will likely be lower than the $163 last year. But how much lower?  Guidance is coming down and that will continue. One silver lining is that smart managements will take the opportunity to kitchen sink any and all corporate problems into 1Q and 2Q EPS, corona related or not. But I’m getting ahead of myself.

Given the over 30% drop, it seems to me the market has already discounted a terrible 2020 earnings. History suggests a permanent 30% drop in EPS isn’t rationale. Likely, institution al investors are already looking at 2021 EPS.

If COVID-19 continues to be a serious pandemic with a long trajectory then here are some stocks whose businesses I think could outperform in terms of EPS and perhaps their stock prices as well. They run from healthcare to videogames. (See chart nearby.)  (The writer currently owns GILD shares.)

Where I could be wrong:  The coronavirus spread is unpredictable and its mortality rate could worsen appreciably. It could take much longer than expected to be contained.   

Bottom Line:  The stock market has taken a hammer blow and it will stabilize when coronavirus cases peak and when we have a clearer idea of 2020-21 SPX EPS.

Prior “Signals”

Date Topic Subject / Ticker The Signal
3/11/20 Market COVID-19 COVID-19 Worry Overblown; Market Discounts Recession
3/4/20 Stock iHeartMedia (IHRT) iHeartMedia Stock Could Rise on Cost Cuts, Digital Revenue
2/26/20 Market South Korean Stock Market When Virus Fears Ease, Hard Hit Korean Stocks Look Cheap
2/19/20 Q&A Atlantic Investment Management Atlantic’s Concentrated Approach Yields Strong Returns
2/12/20 Stock Casper Sleep (CSPR) Casper Stock Might Not Let You Get a Whole Lot of Sleep
2/5/20 Stock Arch Coal (ARCH) After Sentiment Plunge, Arch Coal Stock Looks Inexpensive
1/29/20 Sector Healthcare Healthcare Looks Inexpensive; Some Healthy ETFs to Play
1/22/20 Stock Spirit Airlines (SAVE) Why Spirit Airlines Shares Could Take Off in 2020
1/15/20 Market 4Q19 EPS Season Market to Focus on SPX EPS Growth after 4Q19 EPS Season
1/8/20 Stock Alibaba (BABA), Tencent (700 HK) Alibaba, Tencent Look Attractive on Strong Growth Potential
1/2/20 Stock 2019 Report Card Signal From Noise 2019 Picks: 74% Win Rate, Beat SPX
12/26/19 Market Stock Market 2020 2020 Could Be the Year “Animal Spirits” Return to Equities
12/18/19 Stock Ulta Beauty (ULTA) Ulta Beauty Shares Whacked 35%; Stock Looks Cheap
12/11/19 Market UK Stock Market Conservative Election Win Should Boost Lagging UK Stocks
12/4/19 Stock Capri Holdings (CPRI) Capri Holdings Recovery, Makeover Could Send Stock Higher
11/27/19 Style Value When a Value Stock Is a Value Trap
Disclosures (show)

Want to receive Regular Market Updates to your Inbox?

I am your default error :)
Reserve Your Seat